Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination
Identifieur interne : 000E42 ( Istex/Corpus ); précédent : 000E41; suivant : 000E43Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination
Auteurs : P. Lees ; R. P. Hunter ; P. T. Reeves ; P. L. ToutainSource :
- Journal of Veterinary Pharmacology and Therapeutics [ 0140-7783 ] ; 2012-04.
English descriptors
- Teeft :
- Achiral, Achiral assays, Active constituents, Active isomer, Albendazole, Albendazole sulphoxide, Algorithm, Analytical method, Analytical methods, Assay, Bioequivalence, Bioequivalence determination, Bioequivalence studies, Bioequivalence study, Blackwell publishing, Carprofen, Centre, Chiral, Chiral centre, Chiral drug, Chiral drugs, Chiral excipients, Chiral inversion, Chirality, Clinical pharmacology, Cmax, Comparative bioavailability studies, Delatour, Drug development, Drug racemates, Enantiomer, Enantiomeric, Enantiomeric pair, Enantiomeric pairs, Enantiomers exhibit, Enantioselective, European journal, Eutomer, Excipients, Gastrointestinal tract, Ibuprofen, Ibuprofen enantiomers, Individual enantiomers, Inversion, Isomer, Jamali, Ketoprofen, Ketoprofen products, Lees, Metabolic effect, Metabolism, Midha, Nerurkar, Nonchiral, Nonlinear pharmacokinetics, Nonstereoselective, Nonstereoselective assay, Nortriptyline, Optical isomers, Oral dosing, Other hand, Pharmaceutical, Pharmaceutical sciences, Pharmacodynamic, Pharmacodynamics, Pharmacokinetic, Pharmacokinetics, Pharmacological, Pharmacology, Plasma protein binding, Potency ratios, Racemate, Racemates, Racemic, Racemic drugs, Regulatory authorities, Separate enantiomers, Side effects, Single chiral centre, Solubility, Srinivas, Statistical power, Stereochemistry, Stereoisomeric, Stereoisomeric drugs, Stereoisomers, Stereoselective, Stereoselective analysis, Stereoselective assays, Stereoselective methods, Stereoselectivity, Such products, Sulphoxide, Sulphoxide metabolites, Systemic circulation, Therapeutics, Total drug, Toutain, Toxicological, Veterinary, Veterinary interest, Veterinary medicine, Veterinary pharmacology, Whilst.
Abstract
Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. J. vet. Pharmacol. Therap.35 (Suppl. 1), 17–29. Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.
Url:
DOI: 10.1111/j.1365-2885.2012.01367.x
Links to Exploration step
ISTEX:428C117F48B2F8ABC37C16C75E0110B71377A2F9Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><author><name sortKey="Lees, P" sort="Lees, P" uniqKey="Lees P" first="P." last="Lees">P. Lees</name><affiliation><mods:affiliation>Royal Veterinary College, Hatfield, UK</mods:affiliation></affiliation></author><author><name sortKey="Hunter, R P" sort="Hunter, R P" uniqKey="Hunter R" first="R. P." last="Hunter">R. P. Hunter</name><affiliation><mods:affiliation>Food Animal Therapeutics, Elanco Animal Health, Greenfield, IN, USA</mods:affiliation></affiliation></author><author><name sortKey="Reeves, P T" sort="Reeves, P T" uniqKey="Reeves P" first="P. T." last="Reeves">P. T. Reeves</name><affiliation><mods:affiliation>Australian Pesticides and Veterinary Medicines Authority, Canberra, ACT, Australia</mods:affiliation></affiliation></author><author><name sortKey="Toutain, P L" sort="Toutain, P L" uniqKey="Toutain P" first="P. L." last="Toutain">P. L. Toutain</name><affiliation><mods:affiliation>Ecole Nationale Veterinaire de Toulouse, 23 Chemin des Capelles 31076, Toulouse, France</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:428C117F48B2F8ABC37C16C75E0110B71377A2F9</idno><date when="2012" year="2012">2012</date><idno type="doi">10.1111/j.1365-2885.2012.01367.x</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000E42</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E42</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><author><name sortKey="Lees, P" sort="Lees, P" uniqKey="Lees P" first="P." last="Lees">P. Lees</name><affiliation><mods:affiliation>Royal Veterinary College, Hatfield, UK</mods:affiliation></affiliation></author><author><name sortKey="Hunter, R P" sort="Hunter, R P" uniqKey="Hunter R" first="R. P." last="Hunter">R. P. Hunter</name><affiliation><mods:affiliation>Food Animal Therapeutics, Elanco Animal Health, Greenfield, IN, USA</mods:affiliation></affiliation></author><author><name sortKey="Reeves, P T" sort="Reeves, P T" uniqKey="Reeves P" first="P. T." last="Reeves">P. T. Reeves</name><affiliation><mods:affiliation>Australian Pesticides and Veterinary Medicines Authority, Canberra, ACT, Australia</mods:affiliation></affiliation></author><author><name sortKey="Toutain, P L" sort="Toutain, P L" uniqKey="Toutain P" first="P. L." last="Toutain">P. L. Toutain</name><affiliation><mods:affiliation>Ecole Nationale Veterinaire de Toulouse, 23 Chemin des Capelles 31076, Toulouse, France</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Veterinary Pharmacology and Therapeutics</title><title level="j" type="sub">Bioequivalence</title><title level="j" type="alt">JOURNAL OF VETERINARY PHARMACOLOGY THERAPEUTICS</title><idno type="ISSN">0140-7783</idno><idno type="eISSN">1365-2885</idno><imprint><biblScope unit="vol">35</biblScope><biblScope unit="issue">s1</biblScope><biblScope unit="page" from="17">17</biblScope><biblScope unit="page" to="29">29</biblScope><biblScope unit="page-count">13</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2012-04">2012-04</date></imprint><idno type="ISSN">0140-7783</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0140-7783</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Achiral</term><term>Achiral assays</term><term>Active constituents</term><term>Active isomer</term><term>Albendazole</term><term>Albendazole sulphoxide</term><term>Algorithm</term><term>Analytical method</term><term>Analytical methods</term><term>Assay</term><term>Bioequivalence</term><term>Bioequivalence determination</term><term>Bioequivalence studies</term><term>Bioequivalence study</term><term>Blackwell publishing</term><term>Carprofen</term><term>Centre</term><term>Chiral</term><term>Chiral centre</term><term>Chiral drug</term><term>Chiral drugs</term><term>Chiral excipients</term><term>Chiral inversion</term><term>Chirality</term><term>Clinical pharmacology</term><term>Cmax</term><term>Comparative bioavailability studies</term><term>Delatour</term><term>Drug development</term><term>Drug racemates</term><term>Enantiomer</term><term>Enantiomeric</term><term>Enantiomeric pair</term><term>Enantiomeric pairs</term><term>Enantiomers exhibit</term><term>Enantioselective</term><term>European journal</term><term>Eutomer</term><term>Excipients</term><term>Gastrointestinal tract</term><term>Ibuprofen</term><term>Ibuprofen enantiomers</term><term>Individual enantiomers</term><term>Inversion</term><term>Isomer</term><term>Jamali</term><term>Ketoprofen</term><term>Ketoprofen products</term><term>Lees</term><term>Metabolic effect</term><term>Metabolism</term><term>Midha</term><term>Nerurkar</term><term>Nonchiral</term><term>Nonlinear pharmacokinetics</term><term>Nonstereoselective</term><term>Nonstereoselective assay</term><term>Nortriptyline</term><term>Optical isomers</term><term>Oral dosing</term><term>Other hand</term><term>Pharmaceutical</term><term>Pharmaceutical sciences</term><term>Pharmacodynamic</term><term>Pharmacodynamics</term><term>Pharmacokinetic</term><term>Pharmacokinetics</term><term>Pharmacological</term><term>Pharmacology</term><term>Plasma protein binding</term><term>Potency ratios</term><term>Racemate</term><term>Racemates</term><term>Racemic</term><term>Racemic drugs</term><term>Regulatory authorities</term><term>Separate enantiomers</term><term>Side effects</term><term>Single chiral centre</term><term>Solubility</term><term>Srinivas</term><term>Statistical power</term><term>Stereochemistry</term><term>Stereoisomeric</term><term>Stereoisomeric drugs</term><term>Stereoisomers</term><term>Stereoselective</term><term>Stereoselective analysis</term><term>Stereoselective assays</term><term>Stereoselective methods</term><term>Stereoselectivity</term><term>Such products</term><term>Sulphoxide</term><term>Sulphoxide metabolites</term><term>Systemic circulation</term><term>Therapeutics</term><term>Total drug</term><term>Toutain</term><term>Toxicological</term><term>Veterinary</term><term>Veterinary interest</term><term>Veterinary medicine</term><term>Veterinary pharmacology</term><term>Whilst</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. J. vet. Pharmacol. Therap.35 (Suppl. 1), 17–29. Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.</div></front></TEI><istex><corpusName>wiley</corpusName><keywords><teeft><json:string>enantiomer</json:string><json:string>bioequivalence</json:string><json:string>chiral</json:string><json:string>stereoselective</json:string><json:string>pharmacokinetics</json:string><json:string>pharmacology</json:string><json:string>isomer</json:string><json:string>cmax</json:string><json:string>carprofen</json:string><json:string>enantiomeric</json:string><json:string>midha</json:string><json:string>racemic</json:string><json:string>pharmacokinetic</json:string><json:string>bioequivalence studies</json:string><json:string>assay</json:string><json:string>nonstereoselective</json:string><json:string>blackwell publishing</json:string><json:string>total drug</json:string><json:string>pharmacodynamics</json:string><json:string>enantioselective</json:string><json:string>chirality</json:string><json:string>stereoisomeric</json:string><json:string>racemate</json:string><json:string>delatour</json:string><json:string>albendazole</json:string><json:string>clinical pharmacology</json:string><json:string>racemates</json:string><json:string>therapeutics</json:string><json:string>eutomer</json:string><json:string>ibuprofen</json:string><json:string>stereoisomeric drugs</json:string><json:string>jamali</json:string><json:string>achiral</json:string><json:string>stereoselectivity</json:string><json:string>srinivas</json:string><json:string>nonchiral</json:string><json:string>nerurkar</json:string><json:string>sulphoxide</json:string><json:string>solubility</json:string><json:string>stereoisomers</json:string><json:string>lees</json:string><json:string>ketoprofen</json:string><json:string>chiral drugs</json:string><json:string>excipients</json:string><json:string>nortriptyline</json:string><json:string>stereochemistry</json:string><json:string>pharmacodynamic</json:string><json:string>veterinary medicine</json:string><json:string>analytical method</json:string><json:string>analytical methods</json:string><json:string>toxicological</json:string><json:string>enantiomeric pair</json:string><json:string>whilst</json:string><json:string>toutain</json:string><json:string>racemic drugs</json:string><json:string>pharmaceutical sciences</json:string><json:string>individual enantiomers</json:string><json:string>algorithm</json:string><json:string>active constituents</json:string><json:string>ibuprofen enantiomers</json:string><json:string>bioequivalence determination</json:string><json:string>drug racemates</json:string><json:string>chiral inversion</json:string><json:string>bioequivalence study</json:string><json:string>side effects</json:string><json:string>metabolic effect</json:string><json:string>achiral assays</json:string><json:string>enantiomeric pairs</json:string><json:string>european journal</json:string><json:string>statistical power</json:string><json:string>chiral excipients</json:string><json:string>other hand</json:string><json:string>single chiral centre</json:string><json:string>potency ratios</json:string><json:string>enantiomers exhibit</json:string><json:string>albendazole sulphoxide</json:string><json:string>nonstereoselective assay</json:string><json:string>stereoselective methods</json:string><json:string>inversion</json:string><json:string>metabolism</json:string><json:string>centre</json:string><json:string>oral dosing</json:string><json:string>such products</json:string><json:string>comparative bioavailability studies</json:string><json:string>regulatory authorities</json:string><json:string>stereoselective analysis</json:string><json:string>veterinary interest</json:string><json:string>nonlinear pharmacokinetics</json:string><json:string>optical isomers</json:string><json:string>stereoselective assays</json:string><json:string>plasma protein binding</json:string><json:string>active isomer</json:string><json:string>systemic circulation</json:string><json:string>sulphoxide metabolites</json:string><json:string>drug development</json:string><json:string>gastrointestinal tract</json:string><json:string>separate enantiomers</json:string><json:string>ketoprofen products</json:string><json:string>chiral centre</json:string><json:string>chiral drug</json:string><json:string>veterinary pharmacology</json:string><json:string>veterinary</json:string><json:string>pharmacological</json:string><json:string>pharmaceutical</json:string></teeft></keywords><author><json:item><name>P. LEES</name><affiliations><json:string>Royal Veterinary College, Hatfield, UK</json:string></affiliations></json:item><json:item><name>R. P. HUNTER</name><affiliations><json:string>Food Animal Therapeutics, Elanco Animal Health, Greenfield, IN, USA</json:string></affiliations></json:item><json:item><name>P. T. REEVES</name><affiliations><json:string>Australian Pesticides and Veterinary Medicines Authority, Canberra, ACT, Australia</json:string></affiliations></json:item><json:item><name>P. L. TOUTAIN</name><affiliations><json:string>Ecole Nationale Veterinaire de Toulouse, 23 Chemin des Capelles 31076, Toulouse, France</json:string></affiliations></json:item></author><articleId><json:string>JVP1367</json:string></articleId><arkIstex>ark:/67375/WNG-XMC9PDDP-S</arkIstex><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><abstract>Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. J. vet. Pharmacol. Therap.35 (Suppl. 1), 17–29. Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.</abstract><qualityIndicators><score>8.44</score><pdfWordCount>9687</pdfWordCount><pdfCharCount>66181</pdfCharCount><pdfVersion>1.3</pdfVersion><pdfPageCount>14</pdfPageCount><pdfPageSize>595.276 x 793.701 pts</pdfPageSize><pdfWordsPerPage>692</pdfWordsPerPage><pdfText>true</pdfText><refBibsNative>true</refBibsNative><abstractWordCount>120</abstractWordCount><abstractCharCount>878</abstractCharCount><keywordCount>0</keywordCount></qualityIndicators><title>Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><pmid><json:string>22413788</json:string></pmid><genre><json:string>article</json:string></genre><host><title>Journal of Veterinary Pharmacology and Therapeutics</title><language><json:string>unknown</json:string></language><doi><json:string>10.1111/(ISSN)1365-2885</json:string></doi><issn><json:string>0140-7783</json:string></issn><eissn><json:string>1365-2885</json:string></eissn><publisherId><json:string>JVP</json:string></publisherId><volume>35</volume><issue>s1</issue><pages><first>17</first><last>29</last><total>13</total></pages><genre><json:string>journal</json:string></genre></host><namedEntities><unitex><date><json:string>1990s</json:string><json:string>2012</json:string><json:string>1960s</json:string><json:string>the 20th century</json:string><json:string>1980s</json:string></date><geogName></geogName><orgName><json:string>Blackwell Publishing Ltd</json:string><json:string>EMA</json:string></orgName><orgName_funder></orgName_funder><orgName_provider></orgName_provider><persName><json:string>Peter Lees</json:string></persName><placeName><json:string>Australia</json:string><json:string>UK</json:string><json:string>Canada</json:string><json:string>Canberra</json:string><json:string>Toulouse</json:string></placeName><ref_url></ref_url><ref_bibl><json:string>Qureshi et al. (1994)</json:string><json:string>Tamai et al., 1988</json:string><json:string>Landoni et al. (1997)</json:string><json:string>Midha et al., 1996</json:string><json:string>Soraci et al., 1995</json:string><json:string>Barrett et al., 2000</json:string><json:string>Priymenko et al.(1998)</json:string><json:string>Wechter, 1992</json:string><json:string>Marzo, 1993</json:string><json:string>P. Lees et al.</json:string><json:string>Toutain & Lees, 2004</json:string><json:string>Karim (1996)</json:string><json:string>Tucker and Lennard (1990)</json:string><json:string>Day et al., 1988</json:string><json:string>Midha et al., 1995</json:string><json:string>Suedee et al. (2002)</json:string><json:string>Priymenko et al., 2004</json:string><json:string>Williams et al., 1986</json:string><json:string>Delatour et al. (1991a)</json:string><json:string>Delatour et al., 1994</json:string><json:string>Nerurkar et al. (2005)</json:string><json:string>Ticku et al., 1985</json:string><json:string>Lees et al., 2004</json:string><json:string>King et al., 1994</json:string><json:string>Wang et al. (2010)</json:string><json:string>Mehvar and Jamali (1997)</json:string><json:string>Brocks et al., 1994</json:string><json:string>Hooper, 1993</json:string><json:string>Lees et al. (2004)</json:string><json:string>Jamali, 1992</json:string><json:string>Brocks, 2006</json:string><json:string>Berry & Jamali, 1991</json:string><json:string>Caldwell et al. (1988)</json:string><json:string>Landoni et al., 1997</json:string><json:string>Nation & Sanson, 1994</json:string><json:string>Caldwell et al., 1988</json:string><json:string>Delatour et al., 1990b</json:string><json:string>Srinivas (2004)</json:string><json:string>Nerurkar et al., 1992</json:string><json:string>Nerurkar et al., 2005</json:string><json:string>Ilett et al., 1990</json:string><json:string>Midha et al., 1998</json:string><json:string>Brayden et al., 2010</json:string><json:string>Delatour et al. (1990a,b, 1991a,b)</json:string><json:string>Testa et al., 1993</json:string><json:string>Heard and Brain (2010)</json:string><json:string>Ariens, 1986</json:string><json:string>Lotsch et al. (1995)</json:string><json:string>Nitchuk, 1992</json:string><json:string>EMA, 2010</json:string><json:string>Simonyi et al. (1989)</json:string><json:string>Tanaka et al., 1992</json:string><json:string>Hooper et al., 1992</json:string><json:string>Midha et al. (1998)</json:string><json:string>Delatour et al., 1991b</json:string><json:string>Campbell, 1990</json:string><json:string>Cahn et al. (1956)</json:string><json:string>Najib et al. (2009)</json:string><json:string>Koytchev et al. (1995)</json:string><json:string>Janjikhel and Adeyeye (1999)</json:string></ref_bibl><bibl></bibl></unitex></namedEntities><ark><json:string>ark:/67375/WNG-XMC9PDDP-S</json:string></ark><categories><wos><json:string>1 - science</json:string><json:string>2 - veterinary sciences</json:string><json:string>2 - pharmacology & pharmacy</json:string></wos><scienceMetrix><json:string>1 - applied sciences</json:string><json:string>2 - agriculture, fisheries & forestry</json:string><json:string>3 - veterinary sciences</json:string></scienceMetrix><scopus><json:string>1 - Health Sciences</json:string><json:string>2 - Veterinary</json:string><json:string>3 - General Veterinary</json:string><json:string>1 - Life Sciences</json:string><json:string>2 - Pharmacology, Toxicology and Pharmaceutics</json:string><json:string>3 - Pharmacology</json:string></scopus><inist><json:string>1 - sciences appliquees, technologies et medecines</json:string><json:string>2 - sciences biologiques et medicales</json:string><json:string>3 - sciences medicales</json:string></inist></categories><publicationDate>2012</publicationDate><copyrightDate>2012</copyrightDate><doi><json:string>10.1111/j.1365-2885.2012.01367.x</json:string></doi><id>428C117F48B2F8ABC37C16C75E0110B71377A2F9</id><score>1</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/fulltext.pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/bundle.zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/fulltext.tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><title level="a" type="short">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><licence>© 2012 Blackwell Publishing Ltd</licence></availability><date type="published" when="2012-04"></date></publicationStmt><notesStmt><note type="content-type" subtype="article" source="article" scheme="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</note><note type="publication-type" subtype="journal" scheme="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</note></notesStmt><sourceDesc><biblStruct type="article"><analytic><title level="a" type="main">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><title level="a" type="short">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs</title><author xml:id="author-0000"><persName><forename type="first">P.</forename><surname>LEES</surname></persName><affiliation><address><addrLine>Royal Veterinary College</addrLine><addrLine>Hatfield, UK</addrLine><country key="GB" xml:lang="en">UNITED KINGDOM</country></address></affiliation></author><author xml:id="author-0001"><persName><forename type="first">R. P.</forename><surname>HUNTER</surname></persName><affiliation><address><addrLine>Food Animal Therapeutics</addrLine><addrLine>Elanco Animal Health, Greenfield, IN, USA</addrLine><country key="US" xml:lang="en">UNITED STATES</country></address></affiliation></author><author xml:id="author-0002"><persName><forename type="first">P. T.</forename><surname>REEVES</surname></persName><affiliation><address><addrLine>Australian Pesticides and Veterinary Medicines Authority</addrLine><addrLine>Canberra, ACT, Australia</addrLine><country key="AU" xml:lang="en">AUSTRALIA</country></address></affiliation></author><author xml:id="author-0003"><persName><forename type="first">P. L.</forename><surname>TOUTAIN</surname></persName><affiliation><orgName type="department">Ecole Nationale Veterinaire de Toulouse</orgName><address><addrLine>23 Chemin des Capelles 31076</addrLine><addrLine>Toulouse, France</addrLine><country key="FR" xml:lang="en">FRANCE</country></address></affiliation></author><idno type="istex">428C117F48B2F8ABC37C16C75E0110B71377A2F9</idno><idno type="ark">ark:/67375/WNG-XMC9PDDP-S</idno><idno type="DOI">10.1111/j.1365-2885.2012.01367.x</idno><idno type="unit">JVP1367</idno><idno type="toTypesetVersion">file:JVP.JVP1367.pdf</idno></analytic><monogr><title level="j" type="main">Journal of Veterinary Pharmacology and Therapeutics</title><title level="j" type="sub">Bioequivalence</title><title level="j" type="alt">JOURNAL OF VETERINARY PHARMACOLOGY THERAPEUTICS</title><idno type="pISSN">0140-7783</idno><idno type="eISSN">1365-2885</idno><idno type="book-DOI">10.1111/(ISSN)1365-2885</idno><idno type="book-part-DOI">10.1111/jvp.2012.35.issue-s1</idno><idno type="product">JVP</idno><idno type="publisherDivision">ST</idno><imprint><biblScope unit="vol">35</biblScope><biblScope unit="issue">s1</biblScope><biblScope unit="page" from="17">17</biblScope><biblScope unit="page" to="29">29</biblScope><biblScope unit="page-count">13</biblScope><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="2012-04"></date></imprint></monogr></biblStruct></sourceDesc></fileDesc><encodingDesc><schemaRef type="ODD" url="https://xml-schema.delivery.istex.fr/tei-istex.odd"></schemaRef><appInfo><application ident="pub2tei" version="1.0.10" when="2019-12-20"><label>pub2TEI-ISTEX</label><desc>A set of style sheets for converting XML documents encoded in various scientific publisher formats into a common TEI format.
<ref target="http://www.tei-c.org/">We use TEI</ref></desc></application></appInfo></encodingDesc><profileDesc><abstract xml:lang="en" style="main"><p>Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. <hi rend="italic">J. vet. Pharmacol. Therap.</hi><hi rend="bold">35</hi> (Suppl. 1), 17–29.</p><p>Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.</p></abstract><textClass><keywords rend="tocHeading1"><term>Data Analysis</term></keywords></textClass><langUsage><language ident="en"></language></langUsage></profileDesc><revisionDesc><change when="2019-12-20" who="#istex" xml:id="pub2tei">formatting</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/fulltext.txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1365-2885</doi><issn type="print">0140-7783</issn><issn type="electronic">1365-2885</issn><idGroup><id type="product" value="JVP"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="JOURNAL OF VETERINARY PHARMACOLOGY THERAPEUTICS">Journal of Veterinary Pharmacology and Therapeutics</title></titleGroup></publicationMeta><publicationMeta level="part" position="04001"><doi origin="wiley">10.1111/jvp.2012.35.issue-s1</doi><titleGroup><title type="specialIssueTitle">Bioequivalence</title></titleGroup><numberingGroup><numbering type="journalVolume" number="35">35</numbering><numbering type="supplement">s1</numbering></numberingGroup><coverDate startDate="2012-04">April 2012</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="4" status="forIssue"><doi origin="wiley">10.1111/j.1365-2885.2012.01367.x</doi><idGroup><id type="unit" value="JVP1367"></id></idGroup><countGroup><count type="pageTotal" number="13"></count></countGroup><titleGroup><title type="tocHeading1">Data Analysis</title></titleGroup><copyright>© 2012 Blackwell Publishing Ltd</copyright><eventGroup><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:3.1.3 standalone mode:FullText" date="2012-03-13"></event><event type="firstOnline" date="2012-03-13"></event><event type="publishedOnlineFinalForm" date="2012-03-13"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-01"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.3.4 mode:FullText" date="2015-02-25"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="17">17</numbering><numbering type="pageLast" number="29">29</numbering></numberingGroup><correspondenceTo><i>Professor Peter Lees, Royal Veterinary College, Hawkshead Lane, Hatfield, Herts AL9 7TA, UK. E‐mail:</i><email>plees@rvc.ac.uk</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JVP.JVP1367.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>(Paper received 15 December 2011; accepted for publication 16 December 2011)</unparsedEditorialHistory><countGroup><count type="figureTotal" number="4"></count><count type="tableTotal" number="6"></count></countGroup><titleGroup><title type="main">Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title><title type="shortAuthors"><i>P. Lees</i> et al.</title><title type="short"><i>Pharmacokinetics and pharmacodynamics of stereoisomeric drugs</i></title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1"><personName><givenNames>P.</givenNames><familyName>LEES</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>R. P.</givenNames><familyName>HUNTER</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a3"><personName><givenNames>P. T.</givenNames><familyName>REEVES</familyName></personName></creator><creator creatorRole="author" xml:id="cr4" affiliationRef="#a4"><personName><givenNames>P. L.</givenNames><familyName>TOUTAIN</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="GB"><unparsedAffiliation>Royal Veterinary College, Hatfield, UK</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="US"><unparsedAffiliation>Food Animal Therapeutics, Elanco Animal Health, Greenfield, IN, USA</unparsedAffiliation></affiliation><affiliation xml:id="a3" countryCode="AU"><unparsedAffiliation>Australian Pesticides and Veterinary Medicines Authority, Canberra, ACT, Australia</unparsedAffiliation></affiliation><affiliation xml:id="a4" countryCode="FR"><unparsedAffiliation>Ecole Nationale Veterinaire de Toulouse, 23 Chemin des Capelles 31076, Toulouse, France</unparsedAffiliation></affiliation></affiliationGroup><abstractGroup><abstract type="main" xml:lang="en"><p>Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. <i>J. vet. Pharmacol. Therap.</i><b>35</b> (Suppl. 1), 17–29.</p><p>Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Pharmacokinetics and pharmacodynamics of stereoisomeric drugs</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">LEES</namePart><affiliation>Royal Veterinary College, Hatfield, UK</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R. P.</namePart><namePart type="family">HUNTER</namePart><affiliation>Food Animal Therapeutics, Elanco Animal Health, Greenfield, IN, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P. T.</namePart><namePart type="family">REEVES</namePart><affiliation>Australian Pesticides and Veterinary Medicines Authority, Canberra, ACT, Australia</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P. L.</namePart><namePart type="family">TOUTAIN</namePart><affiliation>Ecole Nationale Veterinaire de Toulouse, 23 Chemin des Capelles 31076, Toulouse, France</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article" authority="ISTEX" authorityURI="https://content-type.data.istex.fr" valueURI="https://content-type.data.istex.fr/ark:/67375/XTP-6N5SZHKN-D">article</genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">2012-04</dateIssued><edition>(Paper received 15 December 2011; accepted for publication 16 December 2011)</edition><copyrightDate encoding="w3cdtf">2012</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><extent unit="figures">4</extent><extent unit="tables">6</extent></physicalDescription><abstract lang="en">Lees, P., Hunter, R. P., Reeves, P. T., Toutain, P. L. Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination. J. vet. Pharmacol. Therap.35 (Suppl. 1), 17–29. Drugs containing one or more chiral centres exist in stereoisomeric molecular forms. Most commonly, drugs containing a single asymmetric carbon atom exist in two enantiomeric forms, designated as eutomer (the more potent) and distomer (the less potent). As well as differences in potency and other pharmacodynamic properties, most members of enantiomeric pairs commonly differ also in their pharmacokinetic profiles. This article reviews factors underlying differences in pharmacological properties of enantiomers. The relevance of such differences for studies designed to evaluate the bioequivalence of products containing chiral drugs is also reviewed.</abstract><relatedItem type="host"><titleInfo><title>Journal of Veterinary Pharmacology and Therapeutics</title></titleInfo><genre type="journal" authority="ISTEX" authorityURI="https://publication-type.data.istex.fr" valueURI="https://publication-type.data.istex.fr/ark:/67375/JMC-0GLKJH51-B">journal</genre><identifier type="ISSN">0140-7783</identifier><identifier type="eISSN">1365-2885</identifier><identifier type="DOI">10.1111/(ISSN)1365-2885</identifier><identifier type="PublisherID">JVP</identifier><part><date>2012</date><detail type="title"><title>Bioequivalence</title></detail><detail type="volume"><caption>vol.</caption><number>35</number></detail><detail type="issue"><caption>Suppl. no.</caption><number>s1</number></detail><extent unit="pages"><start>17</start><end>29</end><total>13</total></extent></part></relatedItem><relatedItem type="references" displayLabel="cit1"><titleInfo><title>Chirality in bioactive agents and its pitfalls</title></titleInfo><name type="personal"><namePart type="given">E.J.</namePart><namePart type="family">Ariens</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ariens, E.J. (1986) Chirality in bioactive agents and its pitfalls. Trends in Pharmaceutical Sciences, 7, 200–205.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>200</start><end>205</end></extent></part><relatedItem type="host"><titleInfo><title>Trends in Pharmaceutical Sciences</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>200</start><end>205</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit2"><titleInfo><title>PhRMA perspective on population and individual bioequivalence</title></titleInfo><name type="personal"><namePart type="given">J.S.</namePart><namePart type="family">Barrett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Batra</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Chow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Cook</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.L.</namePart><namePart type="family">Gould</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.H.</namePart><namePart type="family">Heller</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.W.</namePart><namePart type="family">Lo</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.D.</namePart><namePart type="family">Patterson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.P.</namePart><namePart type="family">Smith</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.A.</namePart><namePart type="family">Stritar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.M.</namePart><namePart type="family">Vega</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Zariffa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Barrett, J.S., Batra, V., Chow, A., Cook, J., Gould, A.L., Heller, A.H., Lo, M.W., Patterson, S.D., Smith, B.P., Stritar, J.A., Vega, J.M. & Zariffa, N. (2000) PhRMA perspective on population and individual bioequivalence. Journal of Clinical Pharmacology, 40, 561–572.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>561</start><end>572</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>561</start><end>572</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit3"><titleInfo><title>Presystemic and systemic chiral inversion of R(−) fenoprofen in the rat</title></titleInfo><name type="personal"><namePart type="given">B.W.</namePart><namePart type="family">Berry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Jamali</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Berry, B.W. & Jamali, F. (1991) Presystemic and systemic chiral inversion of R(−) fenoprofen in the rat. Journal of Pharmacology &l Experimental Therapeutics, 25B, 695–701.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>25B</number></detail><extent unit="pages"><start>695</start><end>701</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Pharmacology &l Experimental Therapeutics</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>25B</number></detail><extent unit="pages"><start>695</start><end>701</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit4"><titleInfo><title>Drug delivery systems in domestic animal species</title></titleInfo><name type="personal"><namePart type="given">D.J.</namePart><namePart type="family">Brayden</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.M.</namePart><namePart type="family">Oudet</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.W.</namePart><namePart type="family">Baird</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book-chapter</genre><relatedItem type="host"><titleInfo><title>Comparative and Veterinary Pharmacology</title></titleInfo><originInfo><publisher>Springer‐Verlag</publisher></originInfo><part><date>2010</date><extent unit="pages"><start>79</start><end>112</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit5"><titleInfo><title>Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics</title></titleInfo><name type="personal"><namePart type="given">D.R.</namePart><namePart type="family">Brocks</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brocks, D.R. (2006) Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharmaceutics & Drug Disposition, 27, 387–406.</note><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>387</start><end>406</end></extent></part><relatedItem type="host"><titleInfo><title>Biopharmaceutics & Drug Disposition</title></titleInfo><part><date>2006</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>387</start><end>406</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit6"><titleInfo><title>Hematologic disposition of hydroxychloroquine enantiomers</title></titleInfo><name type="personal"><namePart type="given">D.R.</namePart><namePart type="family">Brocks</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.J.</namePart><namePart type="family">Skeith</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Johnston</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Emamibafrani</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Davis</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.S.</namePart><namePart type="family">Russell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Jamali</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Brocks, D.R., Skeith, K.J., Johnston, C., Emamibafrani, J., Davis, P., Russell, A.S. & Jamali, F. (1994) Hematologic disposition of hydroxychloroquine enantiomers. Journal of Clinical Pharmacology, 34, 1088–1097.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1088</start><end>1097</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>34</number></detail><extent unit="pages"><start>1088</start><end>1097</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit7"><titleInfo><title>The specification of asymmetric configuration in organic chemistry</title></titleInfo><name type="personal"><namePart type="given">R.S.</namePart><namePart type="family">Cahn</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.K.</namePart><namePart type="family">Ingold</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">V.</namePart><namePart type="family">Prelog</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Cahn, R.S., Ingold, C.K. & Prelog, V. (1956) The specification of asymmetric configuration in organic chemistry. Experientia, 12, 81–124.</note><part><date>1956</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>81</start><end>124</end></extent></part><relatedItem type="host"><titleInfo><title>Experientia</title></titleInfo><part><date>1956</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>81</start><end>124</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit8"><titleInfo><title>The metabolic chiral inversion and dispositional enantioselectivity of the 2‐arylpropionic acids and their biological consequences</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Caldwell</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.J.</namePart><namePart type="family">Hutt</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Fournel‐Gigleux</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Caldwell, J., Hutt, A.J. & Fournel‐Gigleux, S. (1988) The metabolic chiral inversion and dispositional enantioselectivity of the 2‐arylpropionic acids and their biological consequences. Biochemical Pharmacology, 37, 105–114.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>105</start><end>114</end></extent></part><relatedItem type="host"><titleInfo><title>Biochemical Pharmacology</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>37</number></detail><extent unit="pages"><start>105</start><end>114</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit9"><titleInfo><title>Stereoselectivity in clinical pharmacokinetics and drug development</title></titleInfo><name type="personal"><namePart type="given">D.B.</namePart><namePart type="family">Campbell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Campbell, D.B. (1990) Stereoselectivity in clinical pharmacokinetics and drug development. European Journal of Drug Metabolism and Pharmacokinetics, 15, 109–125.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>109</start><end>125</end></extent></part><relatedItem type="host"><titleInfo><title>European Journal of Drug Metabolism and Pharmacokinetics</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>15</number></detail><extent unit="pages"><start>109</start><end>125</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit10"><titleInfo><title>Stereoselective disposition of ibuprofen enantiomers in synovial fluid</title></titleInfo><name type="personal"><namePart type="given">R.O.</namePart><namePart type="family">Day</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.M.</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.G.</namePart><namePart type="family">Graham</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.J.</namePart><namePart type="family">Lee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.D.</namePart><namePart type="family">Knihinicki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G..D.</namePart><namePart type="family">Champion</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Day, R.O., Williams, K.M., Graham, G.G., Lee, E.J., Knihinicki, R.D. & Champion, G..D. (1988) Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clinical Pharmacology and Therapeutics, 43, 480–487.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>480</start><end>487</end></extent></part><relatedItem type="host"><titleInfo><title>Clinical Pharmacology and Therapeutics</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>43</number></detail><extent unit="pages"><start>480</start><end>487</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit11"><titleInfo><title>Species differences in the generation of the chiral sulphoxide metabolite of albendazole in sheep and rats</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Caude</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Tambutu</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Delatour, P., Benoit, E., Caude, M. & Tambutu, A. (1990a) Species differences in the generation of the chiral sulphoxide metabolite of albendazole in sheep and rats. Chirality, 2, 156–160.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>156</start><end>160</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>2</number></detail><extent unit="pages"><start>156</start><end>160</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit12"><titleInfo><title>Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Garnier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Besse</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Delatour, P., Benoit, E., Garnier, F. & Besse, S. (1990b) Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 13, 361–366.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>361</start><end>366</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Veterinary Pharmacology and Therapeutics</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>361</start><end>366</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit13"><titleInfo><title>Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Besse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Boukraa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Delatour, P., Benoit, E., Besse, S. & Boukraa, A. (1991a) Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica, 21, 217–221.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>217</start><end>221</end></extent></part><relatedItem type="host"><titleInfo><title>Xenobiotica</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>21</number></detail><extent unit="pages"><start>217</start><end>221</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit14"><titleInfo><title>Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Garnier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Caude</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Delatour, P., Garnier, E., Benoit, E. & Caude, I. (1991b) Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Research in Veterinary Science, 50, 134–138.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>134</start><end>138</end></extent></part><relatedItem type="host"><titleInfo><title>Research in Veterinary Science</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>50</number></detail><extent unit="pages"><start>134</start><end>138</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit15"><titleInfo><title>Asymetrie moléculaire et pharmacologie compaŕee</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Besse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Soraci</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Delatour, P., Benoit, E., Besse, S. & Soraci, A. (1994) Asymetrie moléculaire et pharmacologie compaŕee. Revue Medécine Vétérinarie, 145, 551–561.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>551</start><end>561</end></extent></part><relatedItem type="host"><titleInfo><title>Revue Medécine Vétérinarie</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>145</number></detail><extent unit="pages"><start>551</start><end>561</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit16"><titleInfo><title>Draft Guideline on the conduct of bioequivalence studies for veterinary medicinal products</title></titleInfo><name type="corporate"><namePart>EMA</namePart></name><genre>other</genre><part><date>2010</date></part></relatedItem><relatedItem type="references" displayLabel="cit17"><titleInfo><title>Enantioselective pharmacodynamics and pharmacokinetics of chiral non‐steroidal anti‐inflammatory drugs</title></titleInfo><name type="personal"><namePart type="given">A.M.</namePart><namePart type="family">Evans</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Evans, A.M. (1992) Enantioselective pharmacodynamics and pharmacokinetics of chiral non‐steroidal anti‐inflammatory drugs. European Journal of Clinical Pharmacology, 42, 237–256.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>237</start><end>256</end></extent></part><relatedItem type="host"><titleInfo><title>European Journal of Clinical Pharmacology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>42</number></detail><extent unit="pages"><start>237</start><end>256</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit18"><titleInfo><title>A practical approach for evaluating population and individual bioequivalence</title></titleInfo><name type="personal"><namePart type="given">A.L.</namePart><namePart type="family">Gould</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Gould, A.L. (2000) A practical approach for evaluating population and individual bioequivalence. Statistics in Medicine, 19, 2721–2740.</note><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>2721</start><end>2740</end></extent></part><relatedItem type="host"><titleInfo><title>Statistics in Medicine</title></titleInfo><part><date>2000</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><extent unit="pages"><start>2721</start><end>2740</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit19"><titleInfo><title>Does solute stereochemistry influence percutaneous penetration?</title></titleInfo><name type="personal"><namePart type="given">C.M.</namePart><namePart type="family">Heard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.R.</namePart><namePart type="family">Brain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Heard, C.M. & Brain, K.R. (2010) Does solute stereochemistry influence percutaneous penetration? Chirality, 7, 305–309.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>305</start><end>309</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>7</number></detail><extent unit="pages"><start>305</start><end>309</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit20"><titleInfo><title>Are enantioselective assay methods necessary for comparative bioavailability studies on racemic drugs?</title></titleInfo><name type="personal"><namePart type="given">W.D.</namePart><namePart type="family">Hooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hooper, W.D. (1993) Are enantioselective assay methods necessary for comparative bioavailability studies on racemic drugs? Proceedings of Western Pharmacology Society, 36, 167–171.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>167</start><end>171</end></extent></part><relatedItem type="host"><titleInfo><title>Proceedings of Western Pharmacology Society</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>167</start><end>171</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit21"><titleInfo><title>Enantioselective versus non‐enantioselective assays in comparative bioavailability studies with racemic drugs</title></titleInfo><name type="personal"><namePart type="given">W.D.</namePart><namePart type="family">Hooper</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Dickinson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Gal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Hooper, W.D., Dickinson, R.G. & Gal, J. (1992) Enantioselective versus non‐enantioselective assays in comparative bioavailability studies with racemic drugs. Biopharmaceutics & Drug Disposition, 13, 383–387.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>383</start><end>387</end></extent></part><relatedItem type="host"><titleInfo><title>Biopharmaceutics & Drug Disposition</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>13</number></detail><extent unit="pages"><start>383</start><end>387</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit22"><titleInfo><title>Metabolism of drugs and other xenobiotics in the gut lumen and wall</title></titleInfo><name type="personal"><namePart type="given">K.F.</namePart><namePart type="family">Ilett</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.G.</namePart><namePart type="family">Tee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.T.</namePart><namePart type="family">Reeves</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.F.</namePart><namePart type="family">Minchin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ilett, K.F., Tee, L.G., Reeves, P.T. & Minchin, R.F. (1990) Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology and Therapeutics, 46, 67–93.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>67</start><end>93</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmacology and Therapeutics</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>46</number></detail><extent unit="pages"><start>67</start><end>93</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit23"><titleInfo><title>Stereochemistry and bioequivalence</title></titleInfo><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Jamali</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jamali, F. (1992) Stereochemistry and bioequivalence. Journal of Clinical Pharmacology, 32, 930–934.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>930</start><end>934</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>930</start><end>934</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit24"><titleInfo><title>???</title></titleInfo><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Jamali</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">D. S.</namePart><namePart type="family">Collins</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B. W.</namePart><namePart type="family">Berry</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Molder</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Cheung</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">McColl</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H</namePart><namePart type="family">Cheung</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Jamali, F., Collins, D. S., Berry, B. W., Molder, S., Cheung, R., McColl, K. & Cheung, H (1991) ???. Biopharmacology Drug Disposition, 12, 435–445.</note><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>435</start><end>445</end></extent></part><relatedItem type="host"><titleInfo><title>Biopharmacology Drug Disposition</title></titleInfo><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>12</number></detail><extent unit="pages"><start>435</start><end>445</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit25"><titleInfo><title>Dissolution of ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients</title></titleInfo><name type="personal"><namePart type="given">R.K.</namePart><namePart type="family">Janjikhel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.M.</namePart><namePart type="family">Adeyeye</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Janjikhel, R.K. & Adeyeye, C.M. (1999) Dissolution of ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients. Pharmaceutical Development & Technology, 4, 9–17.</note><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>9</start><end>17</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmaceutical Development & Technology</title></titleInfo><part><date>1999</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>9</start><end>17</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit26"><titleInfo><title>Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Karim</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Karim, A. (1996) Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know. Journal of Clinical Pharmacology, 36, 490–499.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>490</start><end>499</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>36</number></detail><extent unit="pages"><start>490</start><end>499</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit27"><titleInfo><title>Bidirectional chiral inversion of the enantiomers of the non‐steroidal anti‐inflammatory drug oxindanac in dogs</title></titleInfo><name type="personal"><namePart type="given">J.N.</namePart><namePart type="family">King</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">Mauron</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">C.</namePart><namePart type="family">LeGoff</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Hauffe</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">King, J.N., Mauron, C., LeGoff, C. & Hauffe, S. (1994) Bidirectional chiral inversion of the enantiomers of the non‐steroidal anti‐inflammatory drug oxindanac in dogs. Chirality, 6, 460–466.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>460</start><end>466</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>460</start><end>466</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit28"><titleInfo><title>Bioequivalence studies of two oral propafenone preparations</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Koytchev</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Alken</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">O.</namePart><namePart type="family">Mayer</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Bohm</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Ellrich</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.G.</namePart><namePart type="family">Waldnerkolblin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Koytchev, R., Alken, R.G., Mayer, O., Bohm, R., Ellrich, A. & Waldnerkolblin, R.G. (1995) Bioequivalence studies of two oral propafenone preparations. Arzneimittel Forschung, 45, 542–545.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>542</start><end>545</end></extent></part><relatedItem type="host"><titleInfo><title>Arzneimittel Forschung</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>542</start><end>545</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit29"><titleInfo><title>Enantioselective behaviour of drugs used in domestic animals: a review</title></titleInfo><name type="personal"><namePart type="given">M.F.</namePart><namePart type="family">Landoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.L.</namePart><namePart type="family">Soraci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Lees</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Landoni, M.F., Soraci, A.L., Delatour, A. & Lees, P. (1997) Enantioselective behaviour of drugs used in domestic animals: a review. Journal of Veterinary Pharmacology and Therapeutics, 20, 1–16.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1</start><end>16</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Veterinary Pharmacology and Therapeutics</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>20</number></detail><extent unit="pages"><start>1</start><end>16</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit30"><titleInfo><title>Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest</title></titleInfo><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Lees</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.F.</namePart><namePart type="family">Landoni</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Giraudel</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Toutain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lees, P., Landoni, M.F., Giraudel, J. & Toutain, P.L. (2004) Pharmacodynamics and pharmacokinetics of nonsteroidal anti‐inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology & Therapeutics, 27, 479–490.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>479</start><end>490</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Veterinary Pharmacology & Therapeutics</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>479</start><end>490</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit31"><titleInfo><title>Effects of flurbiprofen enantiomers on pain‐related chemo‐somatosensory evoked potentials in human subjects</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Lötsch</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Geisslinger</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Mohammadian</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Brune</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Kobal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Lötsch, J., Geisslinger, G., Mohammadian, P., Brune, K. & Kobal, G. (1995) Effects of flurbiprofen enantiomers on pain‐related chemo‐somatosensory evoked potentials in human subjects. British Journal of Clinical Pharmacology, 40, 339–346.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>339</start><end>346</end></extent></part><relatedItem type="host"><titleInfo><title>British Journal of Clinical Pharmacology</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>339</start><end>346</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit32"><titleInfo><title>How incoming guidelines on chiral drugs could impact on the international scenary of drug development</title></titleInfo><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Marzo</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Marzo, A. (1993) How incoming guidelines on chiral drugs could impact on the international scenary of drug development. Bollettino Chimico Farmaceutico, 132, 267–271.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>267</start><end>271</end></extent></part><relatedItem type="host"><titleInfo><title>Bollettino Chimico Farmaceutico</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>132</number></detail><extent unit="pages"><start>267</start><end>271</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit33"><titleInfo><title>Input rate‐dependent stereoselective pharmacokinetics: effect of pulsatile oral input</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Mehvar</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mehvar, R. (1994) Input rate‐dependent stereoselective pharmacokinetics: effect of pulsatile oral input. Chirality, 6, 185–195.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>185</start><end>195</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>6</number></detail><extent unit="pages"><start>185</start><end>195</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit34"><titleInfo><title>Bioequivalence of chiral drugs: stereospecific versus non‐stereospecific methods</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Mehvar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Jamali</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Mehvar, R. & Jamali, F. (1997) Bioequivalence of chiral drugs: stereospecific versus non‐stereospecific methods. Clinical Pharmacokinetics, 33, 122–141.</note><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>122</start><end>141</end></extent></part><relatedItem type="host"><titleInfo><title>Clinical Pharmacokinetics</title></titleInfo><part><date>1997</date><detail type="volume"><caption>vol.</caption><number>33</number></detail><extent unit="pages"><start>122</start><end>141</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit35"><titleInfo><title>Stereoselectivity in bioequivalence studies of nortriptyline</title></titleInfo><name type="personal"><namePart type="given">K.K.</namePart><namePart type="family">Midha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Hubbard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">McKay</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Rawson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Schwede</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Midha, K.K., Hubbard, J.W., McKay, G., Rawson, M. & Schwede, R. (1995) Stereoselectivity in bioequivalence studies of nortriptyline. European Journal of Pharmaceutical Sciences, 84, 1265–1266.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>1265</start><end>1266</end></extent></part><relatedItem type="host"><titleInfo><title>European Journal of Pharmaceutical Sciences</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><extent unit="pages"><start>1265</start><end>1266</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit36"><titleInfo><title>The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half‐life</title></titleInfo><name type="personal"><namePart type="given">K.K.</namePart><namePart type="family">Midha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Hubbard</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Rawson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Schwede</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Midha, K.K., Hubbard, J.W., Rawson, M.J. & Schwede, R. (1996) The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half‐life. European Journal of Pharmaceutical Sciences, 4, 283–292.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>283</start><end>292</end></extent></part><relatedItem type="host"><titleInfo><title>European Journal of Pharmaceutical Sciences</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>283</start><end>292</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit37"><titleInfo><title>The impact of stereoisomerism in bioequivalence studies</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Midha</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">McKay</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.J.</namePart><namePart type="family">Rawson</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Hubbard</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Midha, K., McKay, G., Rawson, M.J. & Hubbard, J.W. (1998) The impact of stereoisomerism in bioequivalence studies. Journal of Pharmaceutical Sciences, 87, 797–802.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>797</start><end>802</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Pharmaceutical Sciences</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>87</number></detail><extent unit="pages"><start>797</start><end>802</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit38"><titleInfo><title>Effect of truncated AUC method on drug bioequivalence in humans</title></titleInfo><name type="personal"><namePart type="given">N.M.</namePart><namePart type="family">Najib</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Salem</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Hasan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">N.M.</namePart><namePart type="family">Idkaidek</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Najib, N.M., Salem, I., Hasan, R. & Idkaidek, N.M. (2009) Effect of truncated AUC method on drug bioequivalence in humans. Journal of Bioequivalence & Bioavailability, 1, 112–114.</note><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>112</start><end>114</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Bioequivalence & Bioavailability</title></titleInfo><part><date>2009</date><detail type="volume"><caption>vol.</caption><number>1</number></detail><extent unit="pages"><start>112</start><end>114</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit39"><titleInfo><title>Bioequivalence requirements for generic products</title></titleInfo><name type="personal"><namePart type="given">R.L.</namePart><namePart type="family">Nation</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">L.N.</namePart><namePart type="family">Sanson</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nation, R.L. & Sanson, L.N. (1994) Bioequivalence requirements for generic products. Pharmacology & Therapeutics, 62, 41–55.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>41</start><end>55</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmacology & Therapeutics</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>62</number></detail><extent unit="pages"><start>41</start><end>55</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit40"><titleInfo><title>Bioequivalence of racemic drugs</title></titleInfo><name type="personal"><namePart type="given">S.G.</namePart><namePart type="family">Nerurkar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.V.</namePart><namePart type="family">Dighe</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.L.</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nerurkar, S.G., Dighe, S.V. & Williams, R.L. (1992) Bioequivalence of racemic drugs. Journal of Clinical Pharmacology, 32, 935–943.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>935</start><end>943</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>935</start><end>943</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit41"><titleInfo><title>Solubility of (±)‐ibuprofen and S(+)‐ibuprofen in the presence of cosolvents and cyclodextrins</title></titleInfo><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Nerurkar</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.W.</namePart><namePart type="family">Beach</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.O.</namePart><namePart type="family">Park</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.W.</namePart><namePart type="family">Jun</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nerurkar, J., Beach, J.W., Park, M.O. & Jun, H.W. (2005) Solubility of (±)‐ibuprofen and S(+)‐ibuprofen in the presence of cosolvents and cyclodextrins. Pharmaceutical Development & Technology, 10, 413–421.</note><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>413</start><end>421</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmaceutical Development & Technology</title></titleInfo><part><date>2005</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>413</start><end>421</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit42"><titleInfo><title>Regulatory requirements for generic chiral drugs</title></titleInfo><name type="personal"><namePart type="given">W.M.</namePart><namePart type="family">Nitchuk</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Nitchuk, W.M. (1992) Regulatory requirements for generic chiral drugs. Journal of Clinical Pharmacology, 32, 953–954.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>953</start><end>954</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>953</start><end>954</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit43"><titleInfo><title>Enantioselectivity of the enterohepatic recycling of carprofen in the dog</title></titleInfo><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Priymenko</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.</namePart><namePart type="family">Garnier</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.P.</namePart><namePart type="family">Ferre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Toutain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Priymenko, N., Garnier, F., Ferre, J.P., Delatour, P. & Toutain, P.L. (1998) Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metabolism & Disposition, 26, 170–176.</note><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>170</start><end>176</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Metabolism & Disposition</title></titleInfo><part><date>1998</date><detail type="volume"><caption>vol.</caption><number>26</number></detail><extent unit="pages"><start>170</start><end>176</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit44"><titleInfo><title>Influence of feeding and analytical method on the bioequivalence of a racemic drug undergoing enantioselective enterohepatic recycling</title></titleInfo><name type="personal"><namePart type="given">N.</namePart><namePart type="family">Priymenko</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.D.</namePart><namePart type="family">Koritz</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.P.</namePart><namePart type="family">Ferre</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.F.</namePart><namePart type="family">Laroute</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Toutain</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Priymenko, N., Koritz, G.D., Ferre, J.P., Laroute, M.F. & Toutain, P.L. (2004) Influence of feeding and analytical method on the bioequivalence of a racemic drug undergoing enantioselective enterohepatic recycling. Journal of Pharmaceutical Sciences, 93, 590–600.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>590</start><end>600</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Pharmaceutical Sciences</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>93</number></detail><extent unit="pages"><start>590</start><end>600</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit45"><titleInfo><title>Pharmacokinetics of two enteric‐coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with dissolution findings</title></titleInfo><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Qureshi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Caille</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Lacasse</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.</namePart><namePart type="family">McGilveray</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Qureshi, S., Caille, G., Lacasse, Y. & McGilveray, I. (1994) Pharmacokinetics of two enteric‐coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with dissolution findings. Pharmaceutical Research, 11, 1669–1672.</note><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>1669</start><end>1672</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmaceutical Research</title></titleInfo><part><date>1994</date><detail type="volume"><caption>vol.</caption><number>11</number></detail><extent unit="pages"><start>1669</start><end>1672</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit46"><titleInfo><title>Signs of the times: the need for a stereochemically informative generic name system</title></titleInfo><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Simonyi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Gal</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Testa</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Simonyi, M., Gal, J. & Testa, B. (1989) Signs of the times: the need for a stereochemically informative generic name system. Trends in Pharmacological Sciences, 10, 349–354.</note><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>349</start><end>354</end></extent></part><relatedItem type="host"><titleInfo><title>Trends in Pharmacological Sciences</title></titleInfo><part><date>1989</date><detail type="volume"><caption>vol.</caption><number>10</number></detail><extent unit="pages"><start>349</start><end>354</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit47"><titleInfo><title>Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses</title></titleInfo><name type="personal"><namePart type="given">A.L.</namePart><namePart type="family">Soraci</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Benoit</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Jaussaud</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Lees</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Delatour</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Soraci, A.L., Benoit, E., Jaussaud, P., Lees, P. & Delatour, P. (1995) Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. American Journal of Veterinary Research, 56, 358–361.</note><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>358</start><end>361</end></extent></part><relatedItem type="host"><titleInfo><title>American Journal of Veterinary Research</title></titleInfo><part><date>1995</date><detail type="volume"><caption>vol.</caption><number>56</number></detail><extent unit="pages"><start>358</start><end>361</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit48"><titleInfo><title>Role of stereoselective assays in bioequivalence studies of racemic drugs: have we reached a consensus?</title></titleInfo><name type="personal"><namePart type="given">N.R.</namePart><namePart type="family">Srinivas</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Srinivas, N.R. (2004) Role of stereoselective assays in bioequivalence studies of racemic drugs: have we reached a consensus? The Journal of Clinical Pharmacology, 44, 115–119.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>115</start><end>119</end></extent></part><relatedItem type="host"><titleInfo><title>The Journal of Clinical Pharmacology</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>44</number></detail><extent unit="pages"><start>115</start><end>119</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit49"><titleInfo><title>Bioequivalence of two tablet formulations of nadolol using single and multiple dose data:assessment using stereospecific and nonstereospecific assays</title></titleInfo><name type="personal"><namePart type="given">N.R.</namePart><namePart type="family">Srinivas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.H.</namePart><namePart type="family">Barr</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.C.</namePart><namePart type="family">Shyu</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Mohandoss</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Chow</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Staggers</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.</namePart><namePart type="family">Balan</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">F.J.</namePart><namePart type="family">Belas</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">I.A.</namePart><namePart type="family">Blair</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.H.</namePart><namePart type="family">Barbhaiya</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Srinivas, N.R., Barr, W.H., Shyu, W.C., Mohandoss, E., Chow, S., Staggers, J., Balan, G., Belas, F.J., Blair, I.A. & Barbhaiya, R.H. (1996) Bioequivalence of two tablet formulations of nadolol using single and multiple dose data:assessment using stereospecific and nonstereospecific assays. Journal of Pharmaceutical Sciences, 85, 299–303.</note><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>299</start><end>303</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Pharmaceutical Sciences</title></titleInfo><part><date>1996</date><detail type="volume"><caption>vol.</caption><number>85</number></detail><extent unit="pages"><start>299</start><end>303</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit50"><titleInfo><title>Stereoselective release behaviors of imprinted bead matrices</title></titleInfo><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Suedee</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Srichana</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Chotivatesin</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G.P.</namePart><namePart type="family">Martin</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Suedee, R., Srichana, T., Chotivatesin, R. & Martin, G.P. (2002) Stereoselective release behaviors of imprinted bead matrices. Drug Development and Industrial Pharmacy, 28, 545–554.</note><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>545</start><end>554</end></extent></part><relatedItem type="host"><titleInfo><title>Drug Development and Industrial Pharmacy</title></titleInfo><part><date>2002</date><detail type="volume"><caption>vol.</caption><number>28</number></detail><extent unit="pages"><start>545</start><end>554</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit51"><titleInfo><title>Stereospecific absorption and degradation of cephalexin</title></titleInfo><name type="personal"><namePart type="given">I.</namePart><namePart type="family">Tamai</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">H.Y.</namePart><namePart type="family">Ling</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.M.</namePart><namePart type="family">Timbul</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.A.</namePart><namePart type="family">Nishikido</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tamai, I., Ling, H.Y., Timbul, S.M. & Nishikido, T.A. (1988) Stereospecific absorption and degradation of cephalexin. Journal of Pharmacy and Pharmacology, 40, 320–324.</note><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>320</start><end>324</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Pharmacy and Pharmacology</title></titleInfo><part><date>1988</date><detail type="volume"><caption>vol.</caption><number>40</number></detail><extent unit="pages"><start>320</start><end>324</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit52"><titleInfo><title>Formation of glycine conjugate and (−)‐ and (+)‐enantiomers from (+)‐(S)‐2‐phenylpropionic acid suggesting the formation of the CoA thioester intermediate in dogs</title></titleInfo><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Tanaka</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Shimomura</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Hirota</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.</namePart><namePart type="family">Nozaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.</namePart><namePart type="family">Ebata</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">W.</namePart><namePart type="family">Takasaki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">E.</namePart><namePart type="family">Sigehara</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Hayashi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Caldwell</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tanaka, Y., Shimomura, Y., Hirota, T., Nozaki, A., Ebata, M., Takasaki, W., Sigehara, E., Hayashi, R. & Caldwell, J. (1992) Formation of glycine conjugate and (−)‐ and (+)‐enantiomers from (+)‐(S)‐2‐phenylpropionic acid suggesting the formation of the CoA thioester intermediate in dogs. Chirality, 4, 342–348.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>342</start><end>348</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>4</number></detail><extent unit="pages"><start>342</start><end>348</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit53"><titleInfo><title>The so called ‘interconversion’ of stereoisomeric drugs: an attempt at clarification</title></titleInfo><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Testa</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.A.</namePart><namePart type="family">Carrup</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Gal</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Testa, B., Carrup, P.A. & Gal, J. (1993) The so called ‘interconversion’ of stereoisomeric drugs: an attempt at clarification. Chirality, 5, 105–111.</note><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>105</start><end>111</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>1993</date><detail type="volume"><caption>vol.</caption><number>5</number></detail><extent unit="pages"><start>105</start><end>111</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit54"><titleInfo><title>Separate sites of action of optical isomers of 1‐methyl‐5‐phenyl‐5‐propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex</title></titleInfo><name type="personal"><namePart type="given">M.K.</namePart><namePart type="family">Ticku</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.K.</namePart><namePart type="family">Rastogi</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Thyagarajan</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Ticku, M.K., Rastogi, S.K. & Thyagarajan, R. (1985) Separate sites of action of optical isomers of 1‐methyl‐5‐phenyl‐5‐propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex. European Journal of Pharmacology, 112, 1–9.</note><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>1</start><end>9</end></extent></part><relatedItem type="host"><titleInfo><title>European Journal of Pharmacology</title></titleInfo><part><date>1985</date><detail type="volume"><caption>vol.</caption><number>112</number></detail><extent unit="pages"><start>1</start><end>9</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit55"><titleInfo><title>Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine</title></titleInfo><name type="personal"><namePart type="given">P.L.</namePart><namePart type="family">Toutain</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Lees</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Toutain, P.L. & Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology & Therapeutics, 27, 467–477.</note><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>467</start><end>477</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Veterinary Pharmacology & Therapeutics</title></titleInfo><part><date>2004</date><detail type="volume"><caption>vol.</caption><number>27</number></detail><extent unit="pages"><start>467</start><end>477</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit56"><titleInfo><title>Enantiomer specific pharmacokinetics</title></titleInfo><name type="personal"><namePart type="given">G.I.</namePart><namePart type="family">Tucker</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">M.S.</namePart><namePart type="family">Lennard</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Tucker, G.I. & Lennard, M.S. (1990) Enantiomer specific pharmacokinetics. Pharmacology and Therapeutics, 45, 309–329.</note><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>309</start><end>329</end></extent></part><relatedItem type="host"><titleInfo><title>Pharmacology and Therapeutics</title></titleInfo><part><date>1990</date><detail type="volume"><caption>vol.</caption><number>45</number></detail><extent unit="pages"><start>309</start><end>329</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit57"><titleInfo><title>Van’t Hoff, J.H. (1898) The Arrangement of Atoms in Space. Longmans Green, London, UK.</title></titleInfo><note type="citation/reference">Van’t Hoff, J.H. (1898) The Arrangement of Atoms in Space. Longmans Green, London, UK.</note><name type="personal"><namePart type="given">J.H.</namePart><namePart type="family">Van’t Hoff</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>book</genre><originInfo><publisher>Longmans Green</publisher></originInfo><part><date>1898</date></part></relatedItem><relatedItem type="references" displayLabel="cit58"><titleInfo><title>Stereoselective transport and uptake of propranolol across human intestinal Caco‐2 cell monolayers</title></titleInfo><name type="personal"><namePart type="given">Y.</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">J.</namePart><namePart type="family">Cao</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">X.</namePart><namePart type="family">Wang</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S.</namePart><namePart type="family">Zeng</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wang, Y., Cao, J., Wang, X. & Zeng, S. (2010) Stereoselective transport and uptake of propranolol across human intestinal Caco‐2 cell monolayers. Chirality, 22, 361–368.</note><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>361</start><end>368</end></extent></part><relatedItem type="host"><titleInfo><title>Chirality</title></titleInfo><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>22</number></detail><extent unit="pages"><start>361</start><end>368</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit59"><titleInfo><title>From controversy to resolution: bioequivalence of racemic drugs – A. bioequivalency and analytical aspects of stereochemistry</title></titleInfo><name type="personal"><namePart type="given">W.J.</namePart><namePart type="family">Wechter</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Wechter, W.J. (1992) From controversy to resolution: bioequivalence of racemic drugs – A. bioequivalency and analytical aspects of stereochemistry. Journal of Clinical Pharmacology, 32, 915–916.</note><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>915</start><end>916</end></extent></part><relatedItem type="host"><titleInfo><title>Journal of Clinical Pharmacology</title></titleInfo><part><date>1992</date><detail type="volume"><caption>vol.</caption><number>32</number></detail><extent unit="pages"><start>915</start><end>916</end></extent></part></relatedItem></relatedItem><relatedItem type="references" displayLabel="cit60"><titleInfo><title>The stereoselective uptake of ibuprofen enantiomers into adipose tissue</title></titleInfo><name type="personal"><namePart type="given">K.</namePart><namePart type="family">Williams</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Day</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">R.</namePart><namePart type="family">Knihinicki</namePart><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">A.P.</namePart><namePart type="family">Duffield</namePart><role><roleTerm type="text">author</roleTerm></role></name><genre>journal-article</genre><note type="citation/reference">Williams, K., Day, R., Knihinicki, R. & Duffield, A.P. (1986) The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochemical Pharmacology, 35, 3403–3405.</note><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>3403</start><end>3405</end></extent></part><relatedItem type="host"><titleInfo><title>Biochemical Pharmacology</title></titleInfo><part><date>1986</date><detail type="volume"><caption>vol.</caption><number>35</number></detail><extent unit="pages"><start>3403</start><end>3405</end></extent></part></relatedItem></relatedItem><identifier type="istex">428C117F48B2F8ABC37C16C75E0110B71377A2F9</identifier><identifier type="ark">ark:/67375/WNG-XMC9PDDP-S</identifier><identifier type="DOI">10.1111/j.1365-2885.2012.01367.x</identifier><identifier type="ArticleID">JVP1367</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2012 Blackwell Publishing Ltd</accessCondition><recordInfo><recordContentSource authority="ISTEX" authorityURI="https://loaded-corpus.data.istex.fr" valueURI="https://loaded-corpus.data.istex.fr/ark:/67375/XBH-L0C46X92-X">wiley</recordContentSource><recordOrigin>Converted from (version ) to MODS version 3.6.</recordOrigin><recordCreationDate encoding="w3cdtf">2019-11-15</recordCreationDate></recordInfo></mods><json:item><extension>json</extension><original>false</original><mimetype>application/json</mimetype><uri>https://api.istex.fr/ark:/67375/WNG-XMC9PDDP-S/record.json</uri></json:item></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E42 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000E42 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:428C117F48B2F8ABC37C16C75E0110B71377A2F9
|texte= Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination
}}
| This area was generated with Dilib version V0.6.33. |  |